SPRB - Spruce Biosciences, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
170.27 -6.35 (-3.73%)	---	---	---	1.75 (1.03%)	-12.32 (-7.18%)	1.92 (1.19%)	1.92 (1.19%)

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.32
Diluted EPS:: -0.32
Basic P/E:: -512.25
Diluted P/E:: -512.25
RSI(14) 1m:: 100.0
VWAP:: 163.36
RVol:: 0.1126

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	158.0 -4.0 (-2.47%)	Oct 15 13:28
1m	Price increase 1m	164.65 +3.17 (+1.96%)	Oct 15 11:49
1m	Price decrease 1m	165.0 -2.8 (-1.67%)	Oct 15 11:09
1m	Price increase 1m	167.63 +2.06 (+1.24%)	Oct 15 10:23
60m	Price decrease 60m	166.87 -8.9 (-5.06%)	Oct 15 10:22